Peer-reviewedCC BY-NC-NDTranslational cancer research
A clinicopathological and hematological biomarker-based nomogram for overall survival in early-onset colorectal cancer: development, external validation, and translational implications
- 1The Second Department of General Surgery , The Fourth Hospital of Hebei Medical University , Shijiazhuang , ;
- 2Department of Colorectal Surgery , Qinhuangdao First Hospital , Qinhuangdao , .
Related
- Clinicopathological and molecular characteristics of second primary colorectal cancer in cancer survivors including MSI-H status and anatomical distribution
- Andrographolide in hematological malignancies: potential mechanisms and translational challenges
- Comments on “surface-based brain age index reflects hematological impacts on cognitive development in children with beta-thalassemia major”
- Development and internal validation of a clinicopathological and CT radiomics based prediction model for extracranial distant metastasis after radical resection in early-stage non-small cell lung cancer
- Post-Translational Modification Crosstalk in Gastric Cancer: Molecular Switches, Signaling Networks, and Therapeutic Opportunities, with Comparative Insights from Colorectal Cancer
BibTeX
@article{su2026clinicopathological,
title = {{A clinicopathological and hematological biomarker-based nomogram for overall survival in early-onset colorectal cancer: development, external validation, and translational implications}},
author = {Mingming Su and Changhe Xia and Zhihan Li and Bo Gao and Juan Zhang and Guanglin Wang and Guangquan An and Xiaoling Duan and Jitao Hu and Jiaxu Han and Chenhui Li},
journal = {Translational cancer research},
year = {2026},
month = aug,
url = {https://europepmc.org/article/PMC/PMC13657838},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - A clinicopathological and hematological biomarker-based nomogram for overall survival in early-onset colorectal cancer: development, external validation, and translational implications
AU - Mingming Su
AU - Changhe Xia
AU - Zhihan Li
AU - Bo Gao
AU - Juan Zhang
AU - Guanglin Wang
AU - Guangquan An
AU - Xiaoling Duan
AU - Jitao Hu
AU - Jiaxu Han
AU - Chenhui Li
PY - 2026
DA - 2026/08/18
JO - Translational cancer research
UR - https://europepmc.org/article/PMC/PMC13657838
SN - 2218-676X
ER -